Show simple item record

Catheter-based renal denervation in the treatment of arterial hypertension: An expert consensus statement on behalf of the French Society of Hypertension (SFHTA), French Society of Radiology (SFR), French Society of Interventional Cardiology (GACI), French Society of Cardiology (SFC), French Association of Private Cardiologists (CNCF), French Association of Hospital Cardiologists (CNCH), French Society of Thoracic and Cardiovascular Surgery (SFCTCV) and French Society of Vascular and Endovascular Surgery (SCVE).

dc.rights.licenseopenen_US
dc.contributor.authorPATHAK, Atul
hal.structure.identifierBiologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases
dc.contributor.authorBOULESTREAU, Romain
dc.contributor.authorSAPOVAL, Marc
dc.contributor.authorLANTELME, Pierre
dc.contributor.authorDULY-BOUHANICK, Beatrice
dc.contributor.authorBENAMER, Hakim
dc.contributor.authorBEJAN-ANGOULVANT, Theodora
dc.contributor.authorCREMER, Antoine
dc.contributor.authorAMAR, Laurence
dc.contributor.authorDELARCHE, Nicolas
dc.contributor.authorORMEZZANO, Olivier
dc.contributor.authorSABOURET, Pierre
dc.contributor.authorSILHOL, François
dc.contributor.authorSOSNER, Philippe
dc.contributor.authorLOPEZ-SUBLET, Marilucy
dc.contributor.authorCOHEN, Ariel
dc.contributor.authorCOURAND, Pierre Yves
dc.contributor.authorAZIZI, Michel
dc.date.accessioned2025-01-14T09:15:53Z
dc.date.available2025-01-14T09:15:53Z
dc.date.issued2024-10-01
dc.identifier.issn1875-2128en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/204254
dc.description.abstractEnSeveral high-quality, randomized, sham-controlled trials have provided evidence supporting the efficacy and safety of radiofrequency, ultrasound and alcohol catheter-based renal denervation (RDN) for reducing blood pressure (BP). A French clinical consensus document has therefore been developed to propose guidance for the appropriate use of RDN in the management of hypertension along with a dedicated care pathway and management strategy. The French experts group concluded that RDN can serve as an adjunct therapy for patients with confirmed uncontrolled, resistant essential hypertension despite treatment with≥3 antihypertensive drugs, including a long-acting calcium channel blocker, a renin-angiotensin system blocker and a thiazide/thiazide-like diuretic at maximally tolerated doses. Patients should have (1) an estimated glomerular filtration rate of≥40mL/min/1.73m; (2) an eligible renal artery anatomy on pre-RDN scans and (3) exclusion of secondary forms of hypertension. Additional indications might be considered for patients with difficult-to-control hypertension. Any indication of RDN should be validated by multidisciplinary hypertension teams consisting of both hypertension specialists and endovascular interventionalists in European Society of Hypertension (ESH) Excellence Centres or ESH-BP clinics. Patients should be informed about the benefit/risk ratio of RDN. Expertise in renal artery interventions and training in RDN techniques are needed for endovascular interventionalists conducting RDN procedures while centres offering RDN should have the necessary resources to manage potential complications effectively. Lastly, all patients undergoing RDN should have their data collected in a nationwide French registry to facilitate monitoring and evaluation of RDN outcomes, contributing to ongoing research and quality improvement efforts.
dc.language.isoENen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subject.enHumans
dc.subject.enAntihypertensive Agents
dc.subject.enArterial Pressure
dc.subject.enCatheter Ablation
dc.subject.enConsensus
dc.subject.enHypertension
dc.subject.enKidney
dc.subject.enRenal Artery
dc.subject.enRisk Factors
dc.subject.enSympathectomy
dc.subject.enTreatment Outcome
dc.title.enCatheter-based renal denervation in the treatment of arterial hypertension: An expert consensus statement on behalf of the French Society of Hypertension (SFHTA), French Society of Radiology (SFR), French Society of Interventional Cardiology (GACI), French Society of Cardiology (SFC), French Association of Private Cardiologists (CNCF), French Association of Hospital Cardiologists (CNCH), French Society of Thoracic and Cardiovascular Surgery (SFCTCV) and French Society of Vascular and Endovascular Surgery (SCVE).
dc.title.alternativeArch Cardiovasc Disen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.acvd.2024.05.122en_US
dc.subject.halSciences du Vivant [q-bio]/Médecine humaine et pathologieen_US
dc.identifier.pubmed39332916en_US
bordeaux.journalArchives of cardiovascular diseasesen_US
bordeaux.page601-611en_US
bordeaux.volume117en_US
bordeaux.hal.laboratoriesBiologie des maladies cardiovasculaires (BMC) - UMR 1034en_US
bordeaux.issue10en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.import.sourcepubmed
hal.identifierhal-04885352
hal.version1
hal.date.transferred2025-01-14T09:15:57Z
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exporttrue
workflow.import.sourcepubmed
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Archives%20of%20cardiovascular%20diseases&rft.date=2024-10-01&rft.volume=117&rft.issue=10&rft.spage=601-611&rft.epage=601-611&rft.eissn=1875-2128&rft.issn=1875-2128&rft.au=PATHAK,%20Atul&BOULESTREAU,%20Romain&SAPOVAL,%20Marc&LANTELME,%20Pierre&DULY-BOUHANICK,%20Beatrice&rft.genre=article


Files in this item

Thumbnail
Name:
BMC_ ArchCardiovascDis_2024_Pa ...
Size:
1.464Mb
Format:
PDF
View/Open
Thumbnail
Name:
license_rdf
Size:
914bytes
Format:
application/rdf+xml
View/Open

This item appears in the following Collection(s)

Show simple item record